US Executive Officer Management Changes SEC — February 24, 2026

25-02-2026

ANAVEX LIFE SCIENCES CORP. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected officer, position, appointment or resignation, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

25-02-2026

The company filed an 8-K on February 25, 2026 (AccNo: 0001104659-26-019327) under Item 5.02 disclosing an officer change event dated February 25, 2026. No specific details regarding the affected officer's name, title (e.g., CEO, CFO), nature of change (appointment or resignation), reason, or timing are disclosed. This filing provides no quantitative data, financial metrics, or further context on governance implications.

25-02-2026

Ashford Hospitality Trust Inc filed an 8-K on 2026-02-25 under Item 5.02 disclosing potential departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and under Item 5.03 disclosing amendments to articles of incorporation or bylaws or change in fiscal year. No specific names, positions affected, reasons for changes, timing, or other details are disclosed. This filing provides informational disclosure on leadership and governance matters without quantified financial impacts or directional bias.

25-02-2026

LifeStance Health Group, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change, including key position, appointment or resignation, reasons, or timing, are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned in the provided filing information.

25-02-2026

UnitedHealth Group Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons for change, or any financial metrics are disclosed in the provided filing summary. No quantitative data, period-over-period comparisons, or other metrics are mentioned.

• ·AccNo: 0000731766-26-000046
• ·File size: 189 KB
• ·Event date: 2026-02-25
• ·Sector: NOT_DISCLOSED

25-02-2026

Shoe Carnival Inc filed an 8-K on 2026-02-25 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific details on officer identities, positions affected, reasons for change, financial metrics, or performance comparisons are disclosed in the provided information. No quantitative data or directional indicators provided.

25-02-2026

DiamondRock Hospitality Co filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the affected officer's name, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

25-02-2026

Capri Holdings Ltd filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). Specific details on the officer involved, position affected, reason for change, or any quantitative impacts are NOT_DISCLOSED.

25-02-2026

Confluent, Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing information related to the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any quantitative impacts were provided in the available filing summary. This represents a standard SEC-required disclosure for potential material leadership or governance events.

25-02-2026

Permex Petroleum Corp filed an 8-K on 2026-02-25 disclosing a triggering event that accelerates or increases a direct financial obligation (Item 2.04), an officer change or director departure/election (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). Specific details including the officer's name, title, reason for change, and financial impacts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

25-02-2026

Alkermes plc filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any quantitative impacts are NOT_DISCLOSED. No financial metrics, period-over-period comparisons, or other numerical data are provided.

25-02-2026

Sky Century Investment, Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or impacts are provided. No quantitative financial metrics, performance comparisons, or other material data are disclosed.

25-02-2026

Valmont Industries Inc filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. Specific details including the officer's name, title, reason for change, and whether it is an appointment or departure are NOT_DISCLOSED.

25-02-2026

MIDDLEFIELD BANC CORP filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, positions affected, reasons for change, timing, or financial details are mentioned. No quantitative metrics, performance comparisons, or other impacts are provided.

25-02-2026

Southwest Gas Holdings, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071537) under Item 5.02 disclosing departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are disclosed in the provided filing summary. No positive or negative metrics, scheduled events, or financial impacts are mentioned.

25-02-2026

Honest Company, Inc. filed an 8-K on February 25, 2026, disclosing results of operations and financial condition under Item 2.02, a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, and financial statements and exhibits under Item 9.01. No specific details on the officer change, such as name, title, reason, or timing, are provided. No financial metrics, quantitative data, or performance comparisons are disclosed.

25-02-2026

BiomX Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as key positions affected, names of individuals, reasons for the change, timing, or any quantitative data are disclosed in the provided filing summary. No positive or negative metrics, board impacts, or other governance details are mentioned.

25-02-2026

Hour Loop, Inc. filed an 8-K on 2026-02-25 disclosing officer changes under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

25-02-2026

Dermata Therapeutics, Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names, titles, reasons for changes, timing, or any financial metrics are provided in the available information. No quantitative data, performance comparisons, or further implications are disclosed.

25-02-2026

Marsh & McLennan Companies, Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the key position affected, individuals involved, reasons for the change, or any quantitative impacts are provided in the filing summary. This appears to be an informational disclosure with no additional positive or negative metrics mentioned.

25-02-2026

KRONOS WORLDWIDE INC filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and exhibits under Item 9.01. No specific details on the affected officer's position (e.g., CEO, CFO), name, reason for change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material data are mentioned.

25-02-2026

CareDx, Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details on the officer involved, position affected, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other numerical data are mentioned.

25-02-2026

TaskUs, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001829864-26-000005, Size: 566 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also covers results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). Specific details on the officer involved, position affected, reason for change, financial metrics, or performance comparisons are NOT_DISCLOSED.

25-02-2026

ADMA Biologics, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001140361-26-006781), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with results of operations and financial condition under Item 2.02. Item 9.01 references financial statements and exhibits. No specific details on the officer, position, reason for change, financial metrics, or performance comparisons are disclosed.

• ·Filing size: 847 KB
• ·Event Type: Officer Change

25-02-2026

Eagle Bancorp Inc filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the affected position, individual, reason for change, or timing are disclosed.

25-02-2026

Hamilton Insurance Group, Ltd. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation status, reasons, or any quantitative metrics are disclosed.

25-02-2026

Ecolab Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are disclosed in the provided information.

• ·Filing Accession Number: 0001104659-26-019742
• ·Filing size: 190 KB
• ·Event date: 2026-02-25

25-02-2026

374Water Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Specific details on the affected position, individual involved, reason for change, or timing are NOT_DISCLOSED. No quantitative data, governance impacts, or other metrics are mentioned.

25-02-2026

Avantor, Inc. filed a Form 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. Specific details including the officer's name, title, reason for change, appointment or resignation status, and effective date are NOT_DISCLOSED.

25-02-2026

DIEBOLD NIXDORF, Inc. filed a Form 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific names, titles, reasons for the change, effective dates, internal/external status, or quantitative details such as compensation amounts were disclosed in the provided filing information. No financial metrics, performance comparisons, or other material impacts were mentioned.

25-02-2026

OGE Energy Corp. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071800), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual involved, reason for change, appointment or resignation status, timing, or any compensatory arrangements are disclosed. No quantitative metrics, financial impacts, or governance implications are provided.

25-02-2026

Starfighters Space, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing were disclosed.

25-02-2026

Bit Digital, Inc. filed an 8-K on 2026-02-25 (AccNo: 0001213900-26-020401, Size: 264 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or timing are provided. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

• ·AccNo: 0001213900-26-020401
• ·Event date: February 25, 2026
• ·Sector: NOT_DISCLOSED

25-02-2026

Neuronetics, Inc. filed a Form 8-K on 2026-02-25 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, effective dates, or quantitative compensation data are provided in the filing summary. This represents a standard SEC-required disclosure for material leadership events.

25-02-2026

PENTAIR plc filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed.

• ·AccNo: 0000077360-26-000009
• ·Filing size: 197 KB
• ·Sector: not specified

25-02-2026

Crown Castle Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment or resignation status, reasons, timing, or any quantitative metrics are disclosed in the provided filing information.

25-02-2026

Repay Holdings Corp filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071873), disclosing information under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details on the key position affected, individuals involved, nature of the change (appointment or resignation), reasons, or any quantitative data such as compensation amounts are NOT_DISCLOSED. No other financial metrics, board outcomes, or scheduled events are mentioned.

25-02-2026

HCA Healthcare, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the officer, position, reason, or any quantitative metrics are disclosed.

25-02-2026

Upland Software, Inc. filed an 8-K on February 25, 2026, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer's position, name, appointment or resignation status, reasons for the change, or any financial metrics are disclosed in the provided filing summary. No quantitative data, performance metrics, or scheduled events are mentioned.

25-02-2026

Darling Ingredients Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. Specific details including officer names, positions, reasons for change, or any quantitative impacts are NOT_DISCLOSED.

25-02-2026

Bath & Body Works, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, reasons, or timing are disclosed.

25-02-2026

NeoVolta Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also references Item 9.01 (Financial Statements and Exhibits). No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

25-02-2026

Braemar Hotels & Resorts Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative data are disclosed in the provided filing summary.

25-02-2026

Tevogen Bio Holdings Inc. filed an 8-K on February 25, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also includes Item 5.07 on submission of matters to a vote of security holders and Item 9.01 on financial statements and exhibits. No specific details on positions affected, names, reasons for changes, vote outcomes, or exhibits are disclosed.

25-02-2026

Premier Air Charter Holdings Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are disclosed.

25-02-2026

YIJIA GROUP CORP. filed an 8-K on 2026-02-25 under Item 5.02 disclosing an officer change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. No quantitative data, financial metrics, or other implications are mentioned.

25-02-2026

MARA Holdings, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, or terms are disclosed.

25-02-2026

Vishay Intertechnology Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. Specific details on the affected officer, position, appointment or resignation status, reasons, and timing are NOT_DISCLOSED.

25-02-2026

Flotek Industries Inc. filed an 8-K on February 25, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons for change, timing, or any quantitative financial metrics were disclosed.

25-02-2026

Sarepta Therapeutics, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-072064) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for changes, timing, or quantitative impacts are disclosed. No positive or negative metrics are mentioned.

25-02-2026

DIAMOND HILL INVESTMENT GROUP INC filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed.